73 related articles for article (PubMed ID: 23860250)
1. Design of novel Geldanamycin analogue hsp90 alpha-inhibitor in silico for breast cancer therapy.
Mahanta S; Pilla S; Paul S
Med Hypotheses; 2013 Sep; 81(3):463-9. PubMed ID: 23860250
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs.
Samuni Y; Ishii H; Hyodo F; Samuni U; Krishna MC; Goldstein S; Mitchell JB
Free Radic Biol Med; 2010 Jun; 48(11):1559-63. PubMed ID: 20211249
[TBL] [Abstract][Full Text] [Related]
3. Hsp90, an unlikely ally in the war on cancer.
Barrott JJ; Haystead TA
FEBS J; 2013 Mar; 280(6):1381-96. PubMed ID: 23356585
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs.
Lu X; Xiao L; Wang L; Ruden DM
Biochem Pharmacol; 2012 Apr; 83(8):995-1004. PubMed ID: 22120678
[TBL] [Abstract][Full Text] [Related]
5. Gambogic acid, a natural product inhibitor of Hsp90.
Davenport J; Manjarrez JR; Peterson L; Krumm B; Blagg BS; Matts RL
J Nat Prod; 2011 May; 74(5):1085-92. PubMed ID: 21486005
[TBL] [Abstract][Full Text] [Related]
6. Development of VER-50589 analogs as novel Hsp90 inhibitors.
Fang X; Feng J; Wang K; Luan Y
Bioorg Med Chem Lett; 2023 Jul; 91():129375. PubMed ID: 37315698
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives.
Sellers RP; Alexander LD; Johnson VA; Lin CC; Savage J; Corral R; Moss J; Slugocki TS; Singh EK; Davis MR; Ravula S; Spicer JE; Oelrich JL; Thornquist A; Pan CM; McAlpine SR
Bioorg Med Chem; 2010 Sep; 18(18):6822-56. PubMed ID: 20708938
[TBL] [Abstract][Full Text] [Related]
8. Capsaicin binds the N-terminus of Hsp90, induces lysosomal degradation of Hsp70, and enhances the anti-tumor effects of 17-AAG (Tanespimycin).
Patwardhan CA; Kommalapati VK; Llbiyi T; Singh D; Alfa E; Horuzsko A; Korkaya H; Panda S; Reilly CA; Popik V; Chadli A
Sci Rep; 2023 Aug; 13(1):13790. PubMed ID: 37612326
[TBL] [Abstract][Full Text] [Related]
9. BRCA1/TP53 tumor proteins inhibited by novel analogues of curcumin - Insight from computational modelling, dynamic simulation and experimental validation.
Aloor LJ; Skariyachan S; Raghavamenon AC; Kumar KM; Narayanappa R; Uttarkar A; Niranjan V; Cherian T
Int J Biol Macromol; 2023 Dec; 253(Pt 4):126989. PubMed ID: 37739292
[TBL] [Abstract][Full Text] [Related]
10. Heat shock protein 90 (hsp90) expression and breast cancer.
Zagouri F; Bournakis E; Koutsoukos K; Papadimitriou CA
Pharmaceuticals (Basel); 2012 Sep; 5(9):1008-20. PubMed ID: 24280702
[TBL] [Abstract][Full Text] [Related]
11. Design and Synthesis of Hsp90 Inhibitors with B-Raf and PDHK1 Multi-Target Activity.
Pinzi L; Foschi F; Christodoulou MS; Passarella D; Rastelli G
ChemistryOpen; 2021 Dec; 10(12):1177-1185. PubMed ID: 34633754
[TBL] [Abstract][Full Text] [Related]
12. Geldanamycin confers fungicidal properties to azole by triggering the activation of succinate dehydrogenase.
Xiong J; Wang L; Feng Y; Zhen C; Hang S; Yu J; Lu H; Jiang Y
Life Sci; 2024 May; 348():122699. PubMed ID: 38718854
[TBL] [Abstract][Full Text] [Related]
13. Enniatin A Analogues as Novel Hsp90 Inhibitors that Modulate Triple-Negative Breast Cancer.
Serwetnyk MA; Crowley VM; Brackett CM; Carter TR; Elahi A; Kommalapati VK; Chadli A; Blagg BSJ
ACS Med Chem Lett; 2023 Dec; 14(12):1785-1790. PubMed ID: 38116437
[TBL] [Abstract][Full Text] [Related]
14. Could the Anti-Chaperone VER155008 Replace Temozolomide for Glioma Treatment.
Shervington L; Patil H; Shervington A
J Cancer; 2015; 6(8):786-94. PubMed ID: 26185541
[TBL] [Abstract][Full Text] [Related]
15. Degradable Cross-Linked Nanoassemblies as Drug Carriers for Heat Shock Protein 90 Inhibitor 17-N-Allylamino-17-demethoxy-geldanamycin.
Ponta A; Akter S; Bae Y
Pharmaceuticals (Basel); 2011 Sep; 4(10):1281-1292. PubMed ID: 27721325
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy involving HSP90 inhibitors for combating cancer: an overview of clinical and preclinical progress.
Liu Y; Li C; Liu H; Tan S
Arch Pharm Res; 2024 Apr; ():. PubMed ID: 38632167
[TBL] [Abstract][Full Text] [Related]
17. 17-DMAG diminishes hemorrhage-induced small intestine injury by elevating Bcl-2 protein and inhibiting iNOS pathway, TNF-α increase, and caspase-3 activation.
Kiang JG; Agravante NG; Smith JT; Bowman PD
Cell Biosci; 2011 Jun; 1(1):21. PubMed ID: 21711488
[TBL] [Abstract][Full Text] [Related]
18. Molecular design of anticancer drugs from marine fungi derivatives.
Cao DT; Huong Doan TM; Pham VC; Minh Le TH; Chae JW; Yun HY; Na MK; Kim YH; Pham MQ; Nguyen VH
RSC Adv; 2021 Jun; 11(33):20173-20179. PubMed ID: 35479875
[TBL] [Abstract][Full Text] [Related]
19. Computational Assessment of Chemical Saturation of Analogue Series under Varying Conditions.
Yonchev D; Vogt M; Stumpfe D; Kunimoto R; Miyao T; Bajorath J
ACS Omega; 2018 Nov; 3(11):15799-15808. PubMed ID: 30556013
[TBL] [Abstract][Full Text] [Related]
20. Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases.
Bohush A; Bieganowski P; Filipek A
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
